thiazolidines has been researched along with Obesity in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalla, DSP; Boscá, L; de Las Heras, B; de Oliveira, EM; Maltarollo, VG; Pitta, IR; Pitta, MGR; Rudnicki, M; Silva, JC; Trossini, GHG; Turato, WM | 1 |
| Ahn, JH; Bae, GH; Jeong, HG; Jung, WH; Kang, NS; Kang, SK; Kim, HY; Kim, KY; Park, JS; Park, SB; Rhee, SD | 1 |
| Fukuda-Tsuru, S; Ishii, S; Kakimoto, T; Kiuchi, S; Utsumi, H | 1 |
| Ichikawa, T; Kohno, S; Nakao, K; Onitsuka, Y; Takeshima, F | 1 |
| Ahn, JH; Cha, BS; Choi, CS; Kang, ES; Kim, YW; Lee, BW; Lee, EY; Lee, HC; Oh, H | 1 |
| Moriya, C; Satoh, H | 1 |
| Demuth, HU; McIntosh, CH; Pederson, RA; Pospisilik, JA; Stafford, SG | 1 |
| Arch, JR; Augstein, P; Cawthorne, MA; Demuth, HU; Heinke, P; Hoffmann, T; Meyer, A; Sennitt, MV; Stocker, C; Subramanian, A; Wargent, E | 1 |
| Hirayama, R; Niigata, K; Noshiro, O; Shikama, H; Shimaya, A; Yoneta, T | 1 |
| Akanuma, Y; Ide, T; Kadowaki, T; Mochizuki, T; Murakami, K; Ohashi, M; Tobe, K; Yazaki, Y | 1 |
| Ide, T; Mochizuki, T; Murakami, K; Ohashi, M; Tsunoda, M | 1 |
| Ide, T; Mochizuki, T; Murakami, K; Nakazawa, T | 1 |
12 other study(ies) available for thiazolidines and Obesity
| Article | Year |
|---|---|
GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr
Topics: Adipokines; Animals; Body Weight; Indoles; Inflammation; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity; Peroxisome Proliferator-Activated Receptors; Receptors, LDL; Thiazolidines | 2018 |
Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 3T3-L1 Cells; Adipocytes; Animals; Anti-Inflammatory Agents; Cortisone; Diet; Gene Expression Regulation; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Hypothalamus; Insulin Resistance; Liver; Male; Mice; Mice, Obese; Models, Molecular; Obesity; Pituitary-Adrenal System; Protein Conformation; Thiazolidines | 2013 |
The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice.
Topics: Adipocytes; Adipose Tissue, White; Animals; Anti-Obesity Agents; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Energy Metabolism; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Motor Activity; Obesity; Organ Size; Oxygen Consumption; Pyrazoles; Thiazolidines; Weight Gain | 2014 |
Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes.
Topics: Aged; Biguanides; Body Composition; Body Mass Index; Diabetes Mellitus, Type 2; Diet, Western; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intra-Abdominal Fat; Japan; Logistic Models; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Prevalence; Thiazolidines; Ultrasonography; Waist Circumference | 2014 |
Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Body Composition; Diabetes Mellitus; Diet, High-Fat; Dipeptidyl Peptidase 4; Eating; Energy Metabolism; Enzyme Inhibitors; Female; Glucagon-Like Peptide 1; Glucose Tolerance Test; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Random Allocation; Thiazolidines; Treatment Outcome; Valine; Weight Gain | 2014 |
Teneligliptin Decreases Uric Acid Levels by Reducing Xanthine Dehydrogenase Expression in White Adipose Tissue of Male Wistar Rats.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, White; Animals; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Epididymis; Liver; Male; Mice; Obesity; Pyrazoles; Rats; Rats, Wistar; RNA, Messenger; Thiazolidines; Uric Acid; Xanthine Dehydrogenase | 2016 |
Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study.
Topics: Adipocytes; Animals; Diabetes Mellitus; Dipeptidyl Peptidase 4; Drug Administration Schedule; Enzyme Inhibitors; Glucose Clamp Technique; Glucose Tolerance Test; Insulin; Lipolysis; Liver; Obesity; Pentanoic Acids; Rats; Rats, Zucker; Thiazoles; Thiazolidines | 2002 |
Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Drinking; Drug Therapy, Combination; Drug Tolerance; Eating; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Obesity; Pentanoic Acids; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Time Factors | 2005 |
Role of plasma insulin concentration in regulating glucose and lipid metabolism in lean and obese Zucker rats.
Topics: Administration, Oral; Animals; Blood Glucose; Cholesterol; Cholesterol, HDL; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Hypoglycemic Agents; Insulin; Lipid Metabolism; Lipids; Male; Mice; Mice, Inbred Strains; Obesity; Rats; Rats, Zucker; Thiazoles; Thiazolidines; Time Factors; Triglycerides | 1997 |
A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
Topics: Acyl-CoA Oxidase; Adipose Tissue; Animals; Blood Glucose; Body Weight; Carrier Proteins; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Gene Expression; Hypoglycemic Agents; Insulin; Ligands; Lipid Metabolism; Liver; Male; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Obesity; Organ Size; Oxidoreductases; Radioligand Assay; Rats; Rats, Wistar; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Transcriptional Activation; Triglycerides | 1998 |
Amelioration by KRP-297, a new thiazolidinedione, of impaired glucose uptake in skeletal muscle from obese insulin-resistant animals.
Topics: Animals; Blood Glucose; Glucose; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Thiazoles; Thiazolidines | 1999 |
Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats.
Topics: Administration, Oral; Animals; Chromans; Diabetes Mellitus; Fatty Acids; Hypoglycemic Agents; Liver; Male; Muscle, Skeletal; Obesity; Oxidation-Reduction; Palmitic Acid; Rats; Rats, Zucker; Reference Values; Substrate Specificity; Thiazoles; Thiazolidinediones; Thiazolidines; Triglycerides; Troglitazone | 2000 |